Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
Public ClinicalTrials.gov record NCT00004064. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Phase IIB Study of the Safety and Efficacy of OVAREX MabB43.13 in Ovarian Cancer Patients With an Elevated Serum CA 125 But Without Other Evidence of Disease
Study identification
- NCT ID
- NCT00004064
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AltaRex
- Industry
- Enrollment
- 102 participants
Conditions and interventions
Interventions
- oregovomab Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 1998
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Nov 5, 2013
Started 1998
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Gynecologic Oncology Associates | Newport Beach | California | 92663 | — |
| Lee Memorial Health System | Fort Myers | Florida | 33902 | — |
| Walt Disney Memorial Cancer Institute | Orlando | Florida | 32804 | — |
| H. Lee Moffitt Cancer Center and Research Institute | Tampa | Florida | 33612 | — |
| Indiana University Cancer Center | Indianapolis | Indiana | 46202-5265 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| Mercy Medical Center, Inc. | Baltimore | Maryland | 21202 | — |
| Barnes-Jewish Hospital | St Louis | Missouri | 63110 | — |
| St. John's Mercy Medical Center | St Louis | Missouri | 63141 | — |
| University of Oklahoma College of Medicine | Oklahoma City | Oklahoma | 73190 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
| Palmetto Richland Memorial Hospital | Columbia | South Carolina | 29203 | — |
| Texas Oncology, P.A. | Dallas | Texas | 75246 | — |
| Cancer Center, University of Virginia HSC | Charlottesville | Virginia | 22908 | — |
| Riverside Regional Medical Center | Newport News | Virginia | 23601 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00004064, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 5, 2013 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00004064 live on ClinicalTrials.gov.